Liv Diagnostics AB (559048-6238) was founded in 2016 by a research team together with a group of investors and entrepreneurs. The company is today privately owned.
The development project was initiated in 2014 and is based on many years of basic research at, among other institutions, Karolinska Institutet. The project has recently received external funds from SWElife / VINNOVA and growth loan from the Västra Götalandsregionen (VGR).
The company has a business model that aims to develop the CellRACE product to a stage where a partnership with a global player in the industry can be established. This will ensure availability of resources and infrastructure that are necessary to launch the product in a global market.
Please contact Johan Bjurquist for more information about the company and our business.
Mobile: +46 (0) 73 747 1990